NKLR Posts Deep Losses Amid SPAC Merger, Eyes 2028 Reactor Launch

Ticker: NKLR · Form: 10-Q · Filed: Nov 17, 2025 · CIK: 2067627

Sentiment: mixed

Topics: Nuclear Energy, SPAC Merger, Micro-Modular Reactor, Clean Energy, Pre-Revenue, Liquidity, Going Concern

Related Tickers: NKLR, GSRM

TL;DR

**NKLR is burning cash pre-merger, but the SPAC deal and bridge loan conversion are a lifeline for its ambitious nuclear reactor project.**

AI Summary

Terra Innovatum Global N.V. (NKLR) reported a significant net loss of $2,987 thousand for the three months ended September 30, 2025, and a net loss of $5,580 thousand for the nine months ended September 30, 2025, a substantial increase from a net income of $16 thousand and $36 thousand for the comparable periods in 2024, respectively. Operating expenses surged to $5,899 thousand for the nine months ended September 30, 2025, from $60 thousand in the prior year, primarily driven by increased selling, general, and administrative costs of $5,655 thousand. The company's cash and cash equivalents increased dramatically to $2,151 thousand as of September 30, 2025, from $69 thousand at December 31, 2024, largely due to $5,759 thousand in cash provided by financing activities, including $5,577 thousand from bridge loans. A major business combination with GSR III Acquisition Corp. was consummated on October 9, 2025, subsequent to the reporting period, which converted $5,690 thousand of bridge loans into equity and warrants, significantly improving liquidity and addressing prior going concern doubts. The company is developing the SOLO Micro-Modular Nuclear Reactor, targeting commercial deployment by 2028, and has initiated regulatory engagement with the U.S. Nuclear Regulatory Commission.

Why It Matters

This filing reveals NKLR's pre-merger financial state, characterized by significant losses and high operating expenses, which is critical for investors to understand the baseline before the October 9, 2025, business combination with GSR III. The successful merger and subsequent conversion of $5,690 thousand in bridge loans into equity provide crucial liquidity, mitigating previous going concern doubts and enabling continued development of the SOLO Micro-Modular Nuclear Reactor. For employees, this means greater job security and continued investment in their pioneering nuclear energy technology. Customers and the broader market will be impacted by the potential future deployment of a compact, safe, and economically compelling nuclear energy solution by 2028, potentially disrupting traditional energy infrastructure and offering a competitive alternative to existing energy providers.

Risk Assessment

Risk Level: medium — The company reported an accumulated deficit of $5,617 thousand as of September 30, 2025, and used $3,688 thousand in cash from operating activities for the nine months ended September 30, 2025, indicating historical recurring losses and negative operating cash flows. While the subsequent business combination on October 9, 2025, converted $5,690 thousand of bridge loans into equity and warrants, providing significant liquidity, the company's strategic roadmap targets commercial deployment by 2028, meaning substantial capital expenditures and operational costs will continue for several years without revenue generation.

Analyst Insight

Investors should monitor NKLR's progress on its SOLO Micro-Modular Nuclear Reactor development and regulatory milestones, particularly with the U.S. Nuclear Regulatory Commission. While the recent merger provides a liquidity injection, the company remains pre-revenue with significant future capital needs; consider this a long-term, high-risk growth play contingent on successful technological deployment and market adoption.

Financial Highlights

debt To Equity
N/A
revenue
N/A
operating Margin
N/A
total Assets
$ 3,748K
total Debt
$ 7,978K
net Income
$ (2,987K)
eps
N/A
gross Margin
N/A
cash Position
$ 2,151K
revenue Growth
N/A

Key Numbers

Key Players & Entities

FAQ

What were Terra Innovatum Global N.V.'s key financial results for the nine months ended September 30, 2025?

For the nine months ended September 30, 2025, Terra Innovatum Global N.V. reported a net loss of $5,580 thousand, a significant increase from a net income of $36 thousand for the same period in 2024. Total operating expenses surged to $5,899 thousand, up from $60 thousand in the prior year.

How did the business combination impact Terra Innovatum Global N.V.'s financial position?

The business combination, consummated on October 9, 2025, subsequent to the reporting period, resulted in the conversion of $5,690 thousand of Bridge Loans into equity and warrants. This provided significant additional liquidity, addressing prior substantial doubt about the Company's ability to continue as a going concern.

What is the SOLO Micro-Modular Nuclear Reactor and its strategic importance for Terra Innovatum Global N.V.?

The SOLO Micro-Modular Nuclear Reactor is Terra Innovatum Global N.V.'s pioneering nuclear energy technology, designed to generate 1 MWe of electricity baseload with a continuous operational cycle of up to 15 years. It is strategically important as it represents a breakthrough solution for clean energy production, targeting commercial deployment by 2028 across diverse markets.

What risks did Terra Innovatum Global N.V. identify regarding its ability to continue as a going concern?

As of September 30, 2025, Terra Innovatum Global N.V. had an accumulated deficit of approximately $5,617 thousand and used $3,688 thousand of cash in operating activities for the nine months ended September 30, 2025. These conditions initially raised substantial doubt about the Company's ability to continue as a going concern within one year.

What is Terra Innovatum Global N.V.'s liquidity position after the recent merger?

Subsequent to the October 9, 2025, merger, Terra Innovatum Global N.V.'s liquidity significantly improved due to the conversion of $5,690 thousand of Bridge Loans into equity and warrants. Management believes existing cash will be sufficient to meet working capital and capital expenditure requirements for at least the next 12 months.

When does Terra Innovatum Global N.V. expect to commercially deploy its SOLO reactor?

Terra Innovatum Global N.V.'s strategic roadmap targets commercial deployment of its SOLO Micro-Modular Nuclear Reactor by 2028. The company is currently advancing through critical regulatory milestones to achieve its 2027 First-of-a-Kind (FOAK) reactor completion target.

What regulatory engagements has Terra Innovatum Global N.V. undertaken for its reactor?

Terra Innovatum Global N.V. has initiated regulatory engagement with the U.S. Nuclear Regulatory Commission (NRC) for its SOLO Micro-Modular Nuclear Reactor. This is a crucial step in de-risking its First-of-a-Kind (FOAK) reactor and advancing towards commercial deployment.

What was the change in cash and cash equivalents for Terra Innovatum Global N.V. for the nine months ended September 30, 2025?

For the nine months ended September 30, 2025, Terra Innovatum Global N.V.'s cash and cash equivalents increased by $1,977 thousand, from $69 thousand at the beginning of the period to $2,151 thousand at the end. This was primarily driven by $5,759 thousand in cash provided by financing activities.

What is the significance of Terra Innovatum Global N.V. being an emerging growth company?

As an emerging growth company, Terra Innovatum Global N.V. has elected to use the extended transition period for complying with new or revised accounting standards. This allows them to delay adopting certain standards until they apply to private companies, potentially reducing compliance costs and complexity during their early growth phase.

What are the key differentiators of Terra Innovatum Global N.V.'s SOLO reactor?

The SOLO reactor's key differentiators include a gas-cooled design, multiple safety shutdown mechanisms, safeguard-by-design, a small footprint, and the ability to use commercially available Low Enriched Uranium (LEU). These features aim to reduce regulatory and technological barriers typical in nuclear energy development.

Risk Factors

Industry Context

The nuclear energy sector is undergoing a resurgence driven by the need for reliable, low-carbon baseload power. Micro-modular reactors (MMRs) represent an emerging segment within this industry, promising faster deployment and potentially lower costs compared to traditional large-scale plants. However, the sector remains capital-intensive and subject to stringent regulatory oversight and public perception challenges.

Regulatory Implications

The development and deployment of nuclear technology are heavily regulated by bodies such as the U.S. Nuclear Regulatory Commission. Terra Innovatum Global's progress is contingent on successful navigation of these complex regulatory pathways, which can involve lengthy review processes, safety standard compliance, and environmental impact assessments.

What Investors Should Do

  1. Monitor regulatory progress and milestones for the SOLO reactor.
  2. Analyze the financial impact of the GSR III Acquisition Corp. merger.
  3. Assess the scalability and cost-effectiveness of the SOLO MMR technology.
  4. Evaluate future funding needs and sources.

Key Dates

Glossary

Accumulated deficit
The cumulative net losses of a company that have not been offset by net income. It represents negative retained earnings. (Indicates the company's history of losses, standing at $5,617 thousand as of September 30, 2025.)
Bridge loans
Short-term loans taken out by a company to cover immediate financial needs until longer-term financing is secured. (Provided $5,577 thousand in cash, significantly boosting liquidity, and $5,690 thousand were converted to equity post-period.)
Quotaholders' deficit
The total equity of a company when liabilities exceed assets, resulting in a negative equity position. (The company had a quotaholders' deficit of $(4,230) thousand as of September 30, 2025.)
Micro-Modular Nuclear Reactor (MMR)
A small, factory-built nuclear reactor designed for modular deployment, offering scalability and potentially enhanced safety features. (This is the core technology Terra Innovatum Global is developing (SOLO reactor), targeting commercialization.)
Selling, general and administrative (SG&A) costs
Expenses incurred by a company for selling products and managing its overall business operations, excluding direct production costs. (These costs surged to $5,655 thousand for the nine months ended September 30, 2025, driving the overall increase in operating expenses.)

Year-Over-Year Comparison

Compared to the prior year periods ending September 30, 2024, Terra Innovatum Global N.V. has experienced a dramatic shift from profitability to significant net losses. Revenue figures are not provided for comparison, but operating expenses have surged from $60 thousand to $5,899 thousand, primarily due to increased SG&A. While cash reserves have grown substantially from $69 thousand to $2,151 thousand, this is largely attributed to financing activities, including bridge loans, rather than operational success. New risks related to the substantial increase in operating expenses and the ongoing regulatory process for its nuclear technology are now more prominent.

Filing Stats: 4,640 words · 19 min read · ~15 pages · Grade level 13.5 · Accepted 2025-11-14 20:10:47

Key Financial Figures

Filing Documents

– Financial Information

Part I – Financial Information 1

Financial Statements

Item 1. Financial Statements 1

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 19

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 33

Controls and Procedures

Item 4. Controls and Procedures 33

– Other Information

Part II – Other Information 34

Legal Proceedings

Item 1. Legal Proceedings 34

Risk Factors

Item 1A. Risk Factors 34

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 34

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 34

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 34

Other Information

Item 5. Other Information 34

Exhibits

Item 6. Exhibits 34

Signatures

Signatures 35 i EXPLANATORY NOTE On October 9, 2025, subsequent to the end of the quarterly period ended September 30, 2025, the quarterly period to which this Quarterly Report on Form 10-Q relates, Terra Innovatum Global N.V. (formerly known as Terra Innovatum Global s.r.l.), a public limited liability company organized under Dutch law (the "Company"), consummated its previously announced business combination. Pursuant to several transactions contemplated under the Business Combination Agreement, dated as of April 21, 2025 (the "Business Combination Agreement") by and among Terra Innovatum s.r.l., an Italian limited liability company ("Terra OpCo") and GSR III Acquisition Corp., a Cayman Islands exempted company ("GSR III"), Terra OpCo caused to be formed Terra Innovatum Global s.r.l., an Italian limited liability company (Italian Societ a responsabilit limitata) with the same quotaholders in the same ownership percentages as Terra Opco, ("New TopCo"); New TopCo converted into Terra Innovatum Global N.V., a limited liability company organized under Dutch law, referred to herein as "Terra" or the "Company"; GSR III Cayman Merger Sub (a wholly-owned subsidiary of Terra) was merged with and into GSR III, with GSR III surviving the merger as a wholly owned subsidiary of Terra (the "Merger" and, together with the other transactions contemplated by the Business Combination Agreement, the "Business Combination"). Except as otherwise expressly provided herein, the information in this Quarterly Report on Form 10-Q does not reflect the consummation of the Business Combination which, as discussed above, occurred subsequent to the period covered hereunder. ii

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. Terra Innovatum Global, N.V. (formerly Terra Innovatum Global, Srl.) Consolidated Balance Sheets (Unaudited) (all amounts in USD)(in thousands) September 30, December 31, 2025 2024 Assets Current assets: Cash and cash equivalents $ 2,151 $ 69 Deferred transaction costs 1,114 - Prepaid expenses and other current assets 385 65 Total current assets 3,650 134 Equipment, net 98 - Total assets $ 3,748 $ 134 Liabilities and quotaholders' deficit Current liabilities: Accounts payable $ 3,708 $ 32 Accrued expenses and other current liabilities 221 21 Bridge loans, net 3,557 - Total current liabilities 7,486 53 Related party loan, non-current 325 107 Other non-current liabilities 167 6 Total liabilities 7,978 166 Commitments and contingencies (Note 5) Quotaholders' deficit: Corporate capital 15 3 Additional paid-in capital 1,402 - Accumulated deficit ( 5,617 ) ( 37 ) Accumulated other comprehensive income ( 30 ) 2 Total quotaholders' deficit ( 4,230 ) ( 32 ) Total liabilities and quotaholders' deficit $ 3,748 $ 134 The accompanying notes are an integral part of these unaudited consolidated financial statements. 1 Terra Innovatum Global N.V. (formerly Terra Innovatum Global, Srl.) Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) (all amounts in USD)(in thousands) For The Three Months Ended September 30, For The Nine Months Ended September 30, 2025 2024 2025 2024 Operating expenses: Selling, general and administrative $ 2,135 $ 2 $ 5,655 $ 7 Development costs 155 16 244 53 Total operating expenses 2,290 18 5,899 60 Loss from operations ( 2,290 ) ( 18 ) ( 5,899 ) ( 60 ) Other income (expenses): Other income - related party - 34 - 96 Other expense ( 160 ) - ( 215 ) - Interest expense ( 537 ) - ( 726 ) - Change in fair value - warrant liability - - 1,260 - T

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing